Director General

The European Clinical Research Infrastructure Network (ECRIN-ERIC) is seeking an inspiring and strategic Director General to lead the organisation through its next stage of development and offers a unique opportunity to shape the future of multinational clinical research in Europe.

ECRIN is a non-profit European Research Infrastructure Consortium that supports the conduct of multinational clinical trials across its member countries, enabling Europe to function as a single area for clinical research. Guided by a strong public health mission, ECRIN provides operational services, scientific expertise, and coordination for pan-European clinical studies in all disease areas, working closely with governments, researchers, funders, regulators, patients, and international partners.

Reporting to the ECRIN-ERIC Assembly of Members, the Director General will serve as the legal representative of ECRIN and will be responsible for defining and implementing its strategic direction, overseeing scientific, operational, financial, and human resource management, and driving the organisation’s development within a rapidly evolving European and global clinical research landscape. The role involves close engagement with national governments, European institutions, and key stakeholders to strengthen ECRIN’s membership, partnerships, and international impact.

The successful candidate will have a PhD or equivalent in health or life sciences and a strong track record in medical or life science research, particularly in multinational clinical studies. Proven leadership and management experience in an international context, familiarity with science policy and EU-funded research, and excellent communication skills in English are essential. A collaborative, service-oriented mindset and a strong commitment to strengthening clinical research capacity in Europe are key to success in this role.

The Director General is appointed for a renewable three-year mandate and will be based at ECRIN’s headquarters in central Paris, working with a highly multinational team and travelling regularly within Europe and beyond. The position is full-time, with a competitive salary commensurate with the requirements of the role. ECRIN is an inclusive, equal opportunity and non-discrimination employer, with a gender equality plan, offering attractive conditions and benefits appropriate to an international research organisation.

ECRIN is partnering with Perrett Laver in the recruitment to this role. To apply, or to download further information please visit quoting reference 8238. The deadline for applications is 09.00 BST on Monday 13 th April 2026.

Interviews will take place in the second quarter of 2026, with the successful candidate expected to take up the position in January 2027.

To confidentially get in touch about this role, or for advice on your application please email Lucy Roper on [email protected] .

Should you require access to these documents in alternative formats, please contact Esther Elbro on [email protected] .

If you have comments that would support us to improve access to documentation, or our application processes more generally, please do not hesitate to contact us via [email protected] .

Privacy Policy

Protecting your personal data is of the utmost importance to Perrett Laver and we take this responsibility very seriously. Any information obtained by our trading divisions is held and processed in accordance with the relevant data protection legislation. The data you provide us with is securely stored on our computerised database and transferred to our clients for the purposes of presenting you as a candidate and/or considering your suitability for a role you have registered interest in.

Perrett Laver is a Data Controller and a Data Processor, as defined under the General Data Protection Regulation (GDPR). Our legal basis for much of our data processing activity is ‘Legitimate Interests’. You have the right to object to us processing your data in this way. For more information about this, your rights, and our approach to Data Protection and Privacy, please visit our website .